KPIs & Operating Metrics(New)
Breakdown Of AssetsDeferred RevenueEmployee StatisticsGross MarginGross ProfitNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total RevenueOpex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, Net BreakdownRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By Rest Of WorldRevenue By Rest Of World %Revenue By Rest Of World AnnualRevenue By Rest Of World Annual %Revenue By United StatesRevenue By United States %Revenue By United States AnnualRevenue By United States Annual %Total Net Sales
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Gross Margin (2017 - 2025)

Historic Gross Margin for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to 81.92%.

  • Co-Diagnostics' Gross Margin rose 283100.0% to 81.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 34.03%, marking a year-over-year decrease of 152700.0%. This contributed to the annual value of 74.48% for FY2024, which is 359200.0% up from last year.
  • Per Co-Diagnostics' latest filing, its Gross Margin stood at 81.92% for Q3 2025, which was up 283100.0% from 80.29% recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Gross Margin ranged from a high of 92.02% in Q2 2024 and a low of 132.09% during Q2 2023
  • Over the past 5 years, Co-Diagnostics' median Gross Margin value was 81.78% (recorded in 2022), while the average stood at 52.7%.
  • Per our database at Business Quant, Co-Diagnostics' Gross Margin crashed by -2138700bps in 2023 and then skyrocketed by 2241100bps in 2024.
  • Co-Diagnostics' Gross Margin (Quarter) stood at 87.81% in 2021, then fell by -28bps to 63.2% in 2022, then crashed by -74bps to 16.52% in 2023, then crashed by -529bps to 70.81% in 2024, then surged by 216bps to 81.92% in 2025.
  • Its last three reported values are 81.92% in Q3 2025, 80.29% for Q2 2025, and 57.06% during Q1 2025.